Spotlight on Novo Nordisk: Analyzing the Surge in Options Activity
Spotlight on Novo Nordisk: Analyzing the Surge in Options Activity
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.Financial giants have made a conspicuous bullish move on Novo Nordisk. Our analysis of options history for Novo Nordisk (NYSE:NVO) revealed 11 unusual trades.
金融巨頭在Novo Nordisk上進行了引人注目的看漲舉動。我們對Novo Nordisk (紐交所:NVO)的期權歷史進行分析後發現了11筆飛凡交易。
Delving into the details, we found 45% of traders were bullish, while 36% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $62,093, and 9 were calls, valued at $571,553.
深入了解細節後，我們發現45%的交易者看漲，而36%的交易者表現出看跌傾向。在我們發現的所有交易中，有2筆看跌期權，價值爲$62,093，有9筆看漲期權，價值爲$571,553。
Projected Price Targets
預計價格目標
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $70.0 to $140.0 for Novo Nordisk over the recent three months.
根據交易活動，近三個月來，重要投資者似乎瞄準了Novo Nordisk的價格區間爲$70.0到$140.0。
Insights into Volume & Open Interest
成交量和持倉量分析
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
這些數據可以幫助您跟蹤Coinbase Glb期權的流動性和利益，以給定的行權價格爲基礎。
This data can help you track the liquidity and interest for Novo Nordisk's options for a given strike price.
這些數據可以幫助您跟蹤給定行權價的挪威諾德斯克期權的流動性和興趣。
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Novo Nordisk's whale activity within a strike price range from $70.0 to $140.0 in the last 30 days.
下面，我們可以觀察最近30天內Novo Nordisk在$70.0到$140.0的罷工價位範圍內的看漲和看跌期權的成交量和未平倉量的變化。
Novo Nordisk Call and Put Volume: 30-Day Overview
挪威諾德斯克看漲和看跌成交量：30天概述
Significant Options Trades Detected:
檢測到重大期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVO | CALL | SWEEP | BULLISH | 10/18/24 | $2.87 | $2.85 | $2.86 | $140.00 | $160.0K | 1.1K | 495 |
| NVO | CALL | TRADE | BULLISH | 01/16/26 | $25.0 | $24.15 | $25.0 | $130.00 | $125.0K | 701 | 50 |
| NVO | CALL | SWEEP | BEARISH | 03/21/25 | $14.3 | $14.1 | $14.1 | $135.00 | $63.4K | 726 | 51 |
| NVO | CALL | SWEEP | NEUTRAL | 10/18/24 | $2.92 | $2.86 | $2.89 | $140.00 | $59.8K | 1.1K | 796 |
| NVO | CALL | SWEEP | BULLISH | 10/11/24 | $4.35 | $4.25 | $4.3 | $135.00 | $36.5K | 108 | 85 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVO | 看漲 | SWEEP | 看好 | 10/18/24 | $2.87 | $2.85 | $2.86 | $140.00 | $160.0K | 1.1千 | 495 |
| NVO | 看漲 | 交易 | 看好 | 01/16/26 | $25.0 | $24.15 | $25.0 | $130.00 | $125.0K | 701 | 50 |
| NVO | 看漲 | SWEEP | 看淡 | 03/21/25 | $14.3 | $14.1 | $14.1 | $135.00 | $63.4K | 726 | 51 |
| NVO | 看漲 | SWEEP | 中立 | 10/18/24 | $2.92 | $2.86 | $2.89 | $140.00 | $59.8K | 1.1千 | 796 |
| NVO | 看漲 | SWEEP | 看好 | 10/11/24 | $4.35 | $4.25 | $4.3 | $135.00 | $36.5K | 108 | 85 |
About Novo Nordisk
諾和諾德是一家領先的全球醫療保健公司，致力於研發創新藥品，幫助患糖尿病的患者過上更長壽、更健康的生活，這一傳統已有100多年。這種傳統爲我們提供了經驗和能力，使我們能夠推動變革，幫助人們戰勝其他嚴重的慢性疾病，如肥胖症、罕見的血液和內分泌紊亂。我們始終堅信，持久的成功公式是保持專注，長遠思考，並以財務、社會和環境負責任的方式做生意。諾和諾德在新澤西州設有美國總部，在7個州加上華盛頓特區擁有商業、生產和研究設施，在全國約有8000名員工。有關更多信息，訪問novonordisk-us.com，Facebook、Instagram和X。
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
作爲全球治療糖尿病品牌市場三分之一的領先者，丹麥的Novo Nordisk公司是世界上提供糖尿病護理產品的主要製造商和市場推廣者。該公司製造和銷售各種人體和現代胰島素、GLP-1療法等可注射糖尿病治療藥物、口服降糖藥以及肥胖症治療藥物。Novo Nordisk還有一個生物製藥部門（約佔營收的10%），專門從事血友病和其他疾病的蛋白質療法。
Having examined the options trading patterns of Novo Nordisk, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
經過對Novo Nordisk的期權交易模式的分析，我們現在將關注點直接轉向公司本身。這個轉變使我們能夠深入探究其當前的市場地位和表現。
Where Is Novo Nordisk Standing Right Now?
Novo Nordisk現在處於什麼位置？
- Currently trading with a volume of 292,034, the NVO's price is up by 1.92%, now at $134.59.
- RSI readings suggest the stock is currently is currently neutral between overbought and oversold.
- Anticipated earnings release is in 42 days.
- 目前成交量爲292,034，NVO的價格上漲了1.92%，現在是$134.59。
- RSI讀數表明該股票目前處於中立狀態，處於超買和超賣之間。
- 預計發佈收益的時間爲42天后。
What The Experts Say On Novo Nordisk
專家對諾和諾德的評價
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $160.0.
過去30天裏，共有2位專業分析師對該股票進行了評價，並給出了平均價格目標爲160.0美元。
- Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $160.
- Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $160.
- 反映擔憂，來自Cantor Fitzgerald的分析師將其評級下調爲超重，並設立了新的價格目標爲160美元。
- 反映擔憂，來自Cantor Fitzgerald的分析師將其評級下調爲超重，並設立了新的價格目標爲160美元。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
期權與僅交易股票相比是一種更具風險的資產，但它們具有更高的利潤潛力。認真的期權交易者通過每日學習，進出交易，跟隨多個指標並密切關注市場來管理這種風險。
譯文內容由第三人軟體翻譯。
